& Leech, C
For patients considering switching to compounded semaglutide as a backup option, our switching from tirzepatide to semaglutide guide covers the transition process, including dose equivalencies and what to expect during the changeover
Certain individuals may be at greater risk of experiencing skin side effects
Research peptide only
Third-party testing is essential Legal status varies: clinical trials are fully legal, compounded is legal with prescription in most states, research peptides operate in a grey area FDA approval expected 2027-2028: at that point, retail pharmacy access with standard prescriptions and possible insurance coverage References Jastreboff AM, Kaplan LM, Fras JP, et al
Were here to help every step of the way. Stay tuned for more in our GLP-1 series, where well explore other important facets of these medications: from side effects and mental health impacts, to long-term strategies and the future of weight loss management